🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shanghai
Clinical trial register · China

Clinical Trials in Shanghai

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fudan University454 Ruijin Hospital276 Shanghai Zhongshan Hospital163 RenJi Hospital135 Children's Hospital of Fudan University84
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
3827 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Standardized MRI and Structured Reporting for Esophageal Squamous Cell Carcinoma
NCT07769658Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University
Observational
500
Guangzhou, Zhengzhou, Shanghai, Chengdu, Tianjin, Kunming
2026-09
Not yet open
A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Study of SHR-1179 Injection in Participants With Obesity
NCT07826364Body Weight Management
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 1
50
Shanghai
2026-09
Not yet open
An Open-Label, Multicenter, Phase IB/II Clinical Study of HRS-7172 in Combination With Antitumor Therapy in Participants With Solid Tumors
NCT07806058Pancreatic Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2
140
Shanghai
2026-09
Not yet open
A Phase I Study of GenSci148 Intravitreal Injection for Neovascular Age-related Macular Degeneration, Diabetic Macular Edema and Retinal Vein Occlusion
NCT07817615Neovascular Age-related Macular Degeneration (nAMD), Diabetic Macular Edema (DME), Retinal Vein Occlusion (RVO)
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
60
Shanghai
2026-09
Not yet open
The Study to Evaluate the Plaque Control and Anti-Gingivitis Efficacy of a Toothpaste in Chinese Population
NCT07816406Dental Plaque, Gingivitis
HALEON
Not applicable
120
Shanghai
2026-09
Recruiting
A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
NCT07680764Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb
Phase 2
160
Beijing, Fuzhou, Wuhan, Nanjing, Shanghai, Chengdu, Hangzhou
2026-08-31
Not yet open
A Phase II Study of GFH375 Combined With GFS202A or GFH276 Versus GFH375 Monotherapy in Patients With Previously Treated Locally Advanced Unresectable or Metastatic Pancreatic Cancer Harboring KRAS G12D Mutation
NCT07784374Pancreatic Cancer
Genfleet Therapeutics (Shanghai) Inc.
Phase 2
120
Shanghai
2026-08-31
Not yet open
Hearing Intervention Effects on Brain and Language Development in Children With Bilateral Mild Hearing Loss
NCT07774728Hearing Loss, Bilateral
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Not applicable
236
Shanghai
2026-08-31
Not yet open
A Phase 2 Study of ABSK043 Combined With Osimertinib
NCT07710612Non-Small Cell Lung Cancer With EGFR-mutated and PD-L1 Positive
Abbisko Therapeutics Co, Ltd
Phase 2
72
Guangzhou, Harbin, Wuhan, Shenyang, Shanghai, Taiyuan, Hangzhou
2026-08-31
Not yet open
A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma.
NCT06970496Relapsed or Refractory B Cell Non Hodgkin Lymphoma
Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.
Phase 1
48
Guangzhou, Nanchang, Shanghai, Wenzhou, Xi'an
2026-08-31
Recruiting
Clinical Trial of Thrombectomy Systems
NCT07749820Deep Vein Thrombosis (DVT)
BrosMed Medical Co., Ltd
Not applicable
167
Shanghai
2026-08-30
Not yet open
A Clinical Trial Comparing the Efficacy and Safety of Anyouping® and Platinum-based Chemotherapy With or Without Enlituo® in Advanced Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.
NCT07791745Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)
Taizhou Mabtech Pharmaceutical Co.,Ltd
Phase 2/3
362
Shanghai
2026-08-30
Not yet open
Safety, Tolerability, and Accuracy of a Hydrogel-Based Wearable Dynamic Intraocular Pressure Sensor in Healthy Adults
NCT07770178Intraocular Pressure
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
20
Shanghai
2026-08-30
Not yet open
Clinical Trials of IBI3040 in Healthy Participants and Overweight or Obese Participants
NCT07765160Healthy Participants, Overweight or Obese Participants
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
96
Shanghai
2026-08-30
Not yet open
Night Driving After Trifocal Versus Monofocal IOL Implantation
NCT07755189Cataract, Presbyopia Correction
Jin Yang
Observational
200
Shanghai
2026-08-30
Not yet open
Effects of Blood Flow Restriction Training on Neuromuscular Function and Performance in Artistic Jump Rope Athletes
NCT07750977Neuromuscular Function, Athletic Performance Enhancement
Shanghai University of Sport
Not applicable
30
Shanghai
2026-08-30
Not yet open
A Multicenter, Single Arm Study to Evaluate the Preliminary Efficacy and Safety Profile of Inavolisib in Previously Treated Pancreatic Ductal Adenocarcinoma Patients
NCT07694973Pancreatic Ductal Adenocarcinoma (PDAC)
Fudan University
Phase 2
62
Shanghai
2026-08-29
Recruiting
Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
NCT07778316Small Cell Lung Cancer
Amgen
Phase 3
400
Beijing, Shanghai
2026-08-28
Not yet open
Total Neoadjuvant mFOLFOX6 Plus Suvemcitug and Enlonstobart With Selective Omission of Pelvic Radiotherapy for High-Risk Mid-Rectal Locally Advanced Rectal Cancer
NCT07810114Rectal Cancer
Fudan University
Phase 2
52
Shanghai
2026-08-28
Recruiting
A Phase I Study of ABSK211 in Participants With Advanced Solid Tumors With KRAS Alteration
NCT07718165Solid Tumor (Phase I)
Abbisko Therapeutics Co, Ltd
Phase 1
247
Shanghai
2026-08-28
Recruiting
A Clinical Trial of TQB6426 for Injection in Patients With Advanced Solid Tumors
NCT07730190Advanced Malignancies
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 1
145
Hefei, Beijing, Fuzhou, Guangzhou, Harbin, Zhengzhou, Changsha, Shanghai
2026-08-25
Recruiting
Temporal Interference Stimulation Combined With Tai Chi for Mild Cognitive Impairment
NCT07799584Mild Cognitive Impairment (MCI)
Shanghai University of Sport
Not applicable
120
Shanghai
2026-08-25
Not yet open
Discovery and Validation of Biomarkers for Periodontitis, Dental Caries and Oral Squamous Cell Carcinoma
NCT07745803Oral Squamous Cell Carcinoma (OSCC), Periodontal Disease, Dental Caries
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Observational
4,000
Shanghai
2026-08-25
Not yet open
VBC117First-in-Human Trial of VBC117 in Participants With Advanced Malignant Solid Tumors
NCT07772934Advanced Solid Tumors
VelaVigo Bio Inc
Phase 1/2
260
Zhejiang, Zhengzhou, Changsha, Nanchang, Shengyang, Shanghai, Taiyuan
2026-08-24
Not yet open
Efficacy of Internet-based Cognitive Behavioral Therapy for Insomnia in Patients With Tinnitus and Insomnia
NCT07769515Tinnitus, Insomnia
Eye & ENT Hospital of Fudan University
Not applicable
168
Shanghai
2026-08-24
Not yet open
Electroencephalographic Trajectories During Emergence From Inhalational and Total Intravenous Anesthesia
NCT07806903Emergence From Anesthesia
Ruijin Hospital
Observational
140
Shanghai
2026-08-24
Not yet open
Segmentectomy Versus Lobectomy for Deep Solid-Dominant Early-Stage NSCLC
NCT07698990Non-Small Cell Lung Cancer, Stage IA Non-Small Cell Lung Cancer
Shanghai Chest Hospital
Not applicable
1,200
Shanghai
2026-08-21
Not yet open
A Phase I Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of TJ037130 in Adult Participants With Advanced Solid Tumors
NCT07715747Solid Tumor, Metastatic Ovary Cancer, Metastatic Gastric Cancer, Metastatic Endometrial Carcinoma
TJ Biopharma Co., Ltd.
Phase 1
128
Shanghai
2026-08-21
Not yet open
An Exploratory Clinical Study of Accurate Efficacy Assessment of Neoadjuvant Immunotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma Based on 68Ga-FAPI ([68Ga] Fibroblast Activation Protein Inhibitor)/¹⁸F-FDG (2-Deoxy-2-[¹⁸F]Fluoro-D-glucose) Dual Imaging
NCT07770672Esophageal Cancer, ESCC
Tan Lijie
Phase 2
92
Shanghai
2026-08-20
Not yet open
Home-Based Wearable rTMS Therapy for Moderate to Severe Depression
NCT07775586Major Depressive Disorder
Shanghai Mental Health Center
Not applicable
124
Shanghai
2026-08-20
Not yet open
Zuberitamab in the First Episode of Paediatric Nephrotic Syndrome
NCT07765914Nephrotic Syndrome
Children's Hospital of Fudan University
Phase 3
120
Shanghai, Changsha, Guiyang, Wuhan, Wuxi, Xiamen
2026-08-20
Not yet open
Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
NCT07700979Gastric / Gastroesophageal Junction Adenocarcinoma
Akeso
Phase 3
900
Beijing, Guangzhou, Shanghai
2026-08-20
Not yet open
A Phase III Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe Hypertriglyceridemia
NCT07693777Severe Hypertriglyceridemia (sHTG), Hypertriglyceridemia
Zhejiang Doer Biologics Co., Ltd.
Phase 3
480
Shanghai
2026-08-17
Recruiting
CCTA-Based vs CAG-Based CABG: A Multicenter Pragmatic Non-Inferiority Trial
NCT07769008Coronary Artery Disease, Coronary Artery Bypass Grafting, Coronary Computed Tomography Angiography, Coronary Angiography (CAG)
Ruijin Hospital
Not applicable
826
Shanghai
2026-08-17
Not yet open
ERA in Young Primary Infertile RIF Patients
NCT07767240Recurrent Implantation Failure
ShangHai Ji Ai Genetics & IVF Institute
Observational
400
Shanghai
2026-08-15
Not yet open
A Phase I/II Study of Eque-cel in Subjects Withimmune-mediated Necrotizing Myopathy
NCT07752264Refractory Immune-mediated Necrotizing Myopathy
Nanjing IASO Biotechnology Co., Ltd.
Phase 1/2
27
Beijing, Zhengzhou, Shanghai, Hangzhou
2026-08-15
Recruiting
Postoperative Circulating Tumor DNA Monitoring in Stage I-III Driver-Mutant Colon Adenocarcinoma
NCT07795528Colon Adenocarcinoma, Stage I Colon Cancer, Stage II Colon Cancer, Stage III Colon Cancer
Ruijin Hospital
Observational
392
Shanghai
2026-08-14
Not yet open
Posterosuperior Bundle Pacing for Prevention of Atrial Fibrillation in Patients With Sinus Node Dysfunction
NCT07645066Pacing Therapy, Cardiac Pacing
Shanghai Tong Ren Hospital
Not applicable
300
Anqing, Tongling, Zunyi, Wuhan, Shanghai
2026-08-14
Recruiting
TROP2 NMR Concordance Study
NCT07624318Lung Cancer
AstraZeneca
Observational
3,400
Beijing, Guangzhou, Shanghai
2026-08-13
Recruiting
A Clinical Study of SYS6041 Combination Therapy for Recurrent Ovarian Cancer
NCT07714668Ovarian Cancer, Recurrent Ovarian Cancer
CSPC Megalith Biopharmaceutical Co.,Ltd.
Phase 2
171
Shanghai
2026-08-13
Recruiting
Selective Coverage Versus Comprehensive Coverage Radiotherapy in Poorly Differentiated and Anaplastic Thyroid Cancer
NCT07777536Thyroid Cancer
Fudan University
Phase 2
72
Shanghai
2026-08-12
Recruiting
BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL
NCT07678229Extranodal NK/T-cell Lymphoma
Rong Tao
Phase 3
150
Shanghai
2026-08-11
Recruiting
Clinical and Biological Cohort Study of EBV-Positive T/NK-Cell Lymphoproliferative Diseases
NCT07727083Extranodal NK/T-cell Lymphoma, Aggressive NK-Cell Leukemia, Systemic Chronic Active Epstein-Barr Virus Disease, Epstein-Barr Virus-Positive Nodal T/NK-Cell Lymphoma
Rong Tao
Observational
1,500
Shanghai
2026-08-11
Not yet open
A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Chronic Rhinosinusitis With Nasal Polyps
NCT07755371Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Akeso
Phase 2
75
Shanghai
2026-08-10
Recruiting
SKB264 in Combination With SKB118 for Non-Small Cell Lung Cancer
NCT07697586NSCLC
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2
206
Jilin City, Shanghai
2026-08-07
Recruiting
ACT201 Injection in Healthy Participants and Participants With Chronic Hepatitis B (CHB)
NCT07741461Chronic Hepaititis B
Xiamen Amoytop Biotech Co., Ltd.
Phase 1
72
Shanghai
2026-08-06
Recruiting
A Clinical Trial of HRS5580 for Injection Combined With Palonosetron Hydrochloride for the Prevention of Postoperative Nausea and Vomiting
NCT07709897Prevention of Postoperative Nausea and Vomiting
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 2
260
Shanghai, Tianjin
2026-08-06
Not yet open
Prospective Assessment of Alignment Between Multimodal Artificial Intelligence and Multidisciplinary Team Decisions in Gastrointestinal Oncology
NCT07746830Gastric Cancer, Colorectal Cancer, Gastrointestinal Cancer
Shanghai Minimally Invasive Surgery Center
Observational
69
Shanghai
2026-08-05
Recruiting
Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus
NCT06593392Pruritus, Chronic Kidney Diseases
Vifor Fresenius Medical Care Renal Pharma
Phase 2
18
Chengdu, Guangzhou, Hangzhou, Shanghai, Wuhan, Xi'an
2026-08-04
Active, closed
Huangqi Gegen Decoction for Endothelial Function in Type 2 Diabetes at Very High ASCVD Risk
NCT07775664Type 2 Diabetes Mellitus, Endothelial Dysfunction, Cardiovascular Risk
Putuo Hospital, Shanghai University of Traditional Chinese Medicine
Not applicable
90
Shanghai
2026-08-04
Not yet open
Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients With Early-Onset Parkinson's Disease
NCT07741045Parkinson's Disease (PD), Parkinson Disease 6, Early-Onset
Hangzhou PhecdaMed Co., Ltd.
Phase 3
300
Beijing, Chongqing, Guangzhou, Zhengzhou, Wuhan, Changsha, Suzhou, Shanghai
2026-08-03
Not yet open
Phase I/II Clinical Trial of UX-DA003 Injection for the Treatment of Patients With Parkinson's Disease
NCT07733349Parkinson's Disease
Shanghai UniXell Biotechnology Co., Ltd
Phase 1/2
12
Shanghai
2026-08-03
Not yet open
Efficacy and Safety of Immunoglobulin Plus Firsekibart in Patients With Kawasaki Disease
NCT07686770Kawasaki Disease
Children's Hospital of Fudan University
Phase 2/3
90
Nanchang, Shanghai
2026-08-01
Not yet open
Multimodal Cohort Study of Generalized Anxiety Disorder
NCT07764211Generalized Anxiety Disorder (GAD)
Shanghai Mental Health Center
Observational
400
Shanghai
2026-08-01
Not yet open
Yanlishuang Buccal Dropping Pills for Acute Pharyngitis
NCT07761013Acute Pharyngitis
Beijing University of Chinese Medicine
Not applicable
400
Guangzhou, Guiyang, Harbin, Nanjing, Nanchang, Jinan, Shanghai, Chengdu
2026-08-01
Not yet open
Oropharyngeal Flushing Suction Tube With Laryngoscope for Stroke-Associated Pneumonia
NCT07647666Acute Ischemic Stroke, Stroke-Associated Pneumonia (SAP)
Shanghai Pudong New Area Gongli Hospital
Not applicable
120
Shanghai
2026-08-01
Recruiting
Becotatug Vedotin Combined With a PD-1 Inhibitor in the Treatment of Locally Advanced Recurrent Nasopharyngeal Carcinoma.
NCT07781358Nasopharyngeal Carcinoma (NPC)
Hongmeng Yu
Phase 2
25
Shanghai
2026-08-01
Not yet open
Effects of Exercise Intervention on Sleep Quality and Emotional Problems in College Students With Depressive Symptoms
NCT07738809Depressive Symptoms, Sleep Disturbance
Capital University of Physical Education and Sports, China
Not applicable
80
Shanghai
2026-08-01
Not yet open
Efficacy and Safety of Serplulimab in Combination With Bevacizumab and FOLFIRINOX or NALIRIFOX as Second-Line Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
NCT07733050Metastatic Pancreatic Ductal Adenocarcinoma
Shanghai General Hospital, China
Phase 2
34
Shanghai
2026-08-01
Not yet open
A Prospective Study of Response-adapted Low-dose Radiotherapy Combined With Orelabrutinib for Localized Mucosa-associated Lymphoid Tissue Extranodal Marginal Zone Lymphoma
NCT07705308Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT)
Ruijin Hospital
Phase 2
140
Shanghai
2026-08-01
Recruiting
A Prospective Observational Study Using the FAM-CAM
NCT07694687Patients in ICU, Delirium in the Intensive Care Unit, Family
Shanghai Zhongshan Hospital
Observational
330
Shanghai
2026-08-01
Not yet open
The Clinical Study of Adalimumab Combined With Other Anti-tumor Therapy as a Treatment for Resectable Non-small Cell Lung Cancer
NCT07704645Resectable Non-small Cell Lung Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2
180
Shanghai
2026-08
Not yet open
A Study of BL-B01D1 Plus an Anti-PD-1 Antibody Versus Nab-paclitaxel Plus an Anti-PD-1 Antibody in Patients With Previously Untreated, Locally Advanced, Inoperable or Metastatic Triple-Negative Breast Cancer Whose Tumors Express PD-L1 (PANKU-Breast04)
NCT07729956Triple-Negative Breast Cancer (TNBC)
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
436
Shanghai
2026-08
Not yet open
Eye Tracking for Early Identification of Post-ICU Cognitive Impairment
NCT07676864Post Intensive Care Syndrome (PICS), Cognitive Impairment
Shanghai Zhongshan Hospital
Observational
73
Shanghai
2026-08
Not yet open
A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Primary AL Amyloidosis
NCT07765524Primary Light Chain (AL) Amyloidosis
Shenzhen Fosun Kairos Biotechnology Co., Ltd.
Phase 1/2
32
Guangzhou, Nanning, Zhengzhou, Wuhan, Nanjing, Jinan, Shanghai, Chengdu
2026-08
Recruiting
Dynamic Risk-adapted EBV-DNA and MRI-guided De-concurrent Chemotherapy in Nasopharyngeal Carcinoma
NCT07762976Nasopharyngeal Carcinoma (NPC)
Fudan University
Phase 2
148
Shanghai
2026-08
Not yet open
Response-adapted Postoperative Radiotherapy In Locally Advanced Head and Neck Cancer
NCT07780877Head & Neck Squamous Cell Carcinoma, Locally Advanced Head and Neck Squamous Cell Carcinoma
Fudan University
Phase 2
85
Changsha, Shanghai
2026-08
Not yet open
Closed-loop TBS Targeting rPO for the Core Clinical Features of the Methamphetamine Use Disorder
NCT07775807Methamphetamine Use Disorder, Substance Use Disorder, Cue-reactivity, Craving
Shanghai Mental Health Center
Not applicable
5
Shanghai
2026-08
Not yet open
A Phase III Study of KHN939 in Chinese Patients With Moderate-to-Severe Inactive Thyroid Eye Disease
NCT07720648Thyroid Eye Disease
Beijing Kanghong Biological Medicine Co., Ltd.
Phase 3
117
Shanghai
2026-08
Not yet open
Romiplostim N01 for Injection for Secondary Prophylaxis of CIT in Breast Cancer
NCT07771881Thrombocytopenia Chemotherapy Induced
Fudan University
Phase 2
53
Shanghai
2026-08
Not yet open
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
NCT07759245Pulmonary Disease, Chronic Obstructive
Eli Lilly and Company
Phase 2
606
Baotou, Beijing, Chengdu, Guangzhou, Jiangyin, Jinan, Pingxiang, Shanghai
2026-08
Not yet open
A Study of SI-B036 in Patients With Locally Advanced or Metastatic Head and Neck Tumors and Other Solid Tumors
NCT07763639Head and Neck Tumors, Solid Tumors
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
30
Changsha, Shanghai
2026-08
Not yet open
A Study of LAE118 as Monotherapy and in Combination With Antitumor Agents in Advanced Solid Tumors
NCT07787520Patients With Advanced Solid Tumors
Laekna Limited
Phase 1
150
Hefei, Beijing, Changchun, Shanghai, Hangzhou
2026-08
Not yet open
Probiotic IBNI617 for Moderate to Severe Depression
NCT07728253Major Depressive Disorder (MDD), IBNI617
IBIOME BIOTECHNOLOGY CO., LTD
Not applicable
148
Shanghai
2026-08
Not yet open
FICB for Hip Fracture Pain in Elderly
NCT07762846Hip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures), Postoperative Pain, QoR-15, Fascia Iliaca Block
RenJi Hospital
Not applicable
144
Shanghai
2026-08
Not yet open
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
NCT07775300Depressive Disorder, Major
Eli Lilly and Company
Phase 3
1,000
Beijing, Chaohu, Jinan, Linfen, Shanghai, Suzhou, Tianjin, Wenzhou
2026-08
Not yet open
A Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of PTT-621 in Patients With Moderately to Severely Active Ulcerative Colitis
NCT07747155Ulcerative Colitis (UC)
Pyrotech Therapeutics, Inc.
Phase 2
40
Shanghai
2026-08
Not yet open
Treatment of Chinese Adult Subjects With Moderate to Severe Crohn's Disease With Tabellvi®
NCT07663526Crohn's Disease
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 4
50
Fuyang, Zhengzhou, Zhoukou, Huaian, Yancheng, Meihekou, Shanghai
2026-08
Not yet open
Closed-loop TMS for the Core Clinical Features of the Methamphetamine Use Disorder
NCT07154160Methamphetamine Use Disorder, Substance Use Disorder, Cue-reactivity, Craving
Shanghai Mental Health Center
Not applicable
21
Shanghai
2026-08
Not yet open
A Phase III Study of KHN939 in Chinese Patients With Moderate-to-Severe Active Thyroid Eye Disease
NCT07720635Thyroid Eye Disease
Beijing Kanghong Biological Medicine Co., Ltd.
Phase 3
60
Shanghai
2026-08
Not yet open
A Study Comparing BL-M07D1 With Physician's Choice Therapy in Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Failed Prior Treatment With Oxaliplatin, Fluorouracil and Irinotecan
NCT07730489Colorectal Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
130
Shenyang, Shanghai
2026-08
Recruiting
Phase I Exploratory Study of YOLT-203 in Patients With Primary Hyperoxaluria Type 1 (PH1)
NCT07776626Primary Hyperoxaluria Type 1, PH1
YolTech Therapeutics Co., Ltd
Phase 1
9
Shanghai
2026-08
Not yet open
Diagnostic Accuracy and Safety of the Attention-Deficit/Hyperactivity Disorder Auxiliary Evaluation System (AHEF) in Chinese Children Aged 6 to 12
NCT07683156Attention-Deficit, Hyperactivity Disorder
Chongqing Jinsaixing Medical Technology Co., Ltd
Observational
570
Beijing, Chongqing, Guangzhou, Shenzhen, Nanjing, Changchun, Shanghai, Chengdu
2026-07-31
Recruiting
Real-World Study of Young Patients With Solid Tumors in China
NCT07708935Cancer
Fudan University
Observational
12,000
Shanghai
2026-07-31
Not yet open
The Efficacy and Safety of Donafenib Plus PD-1/L1 Monoclonal Antibodies Plus TACE or HAIC as First-line Treatment for Unresectable Hepatocellular Carcinoma A Multi-center, Retrospective Clinical Study
NCT07724951Hepatocellular Carcinoma (HCC)
Shanghai Zhongshan Hospital
Observational
400
Guangzhou, Nanning, Harbin, Qingdao, Shanghai, Kunming
2026-07-31
Not yet open
Luvometinib in Combination With Serplulimab for NF2-Related Tumors
NCT07708285NF2-related Schwannomatosis, NF2, Neurofibromatosis Type 2, Vestibular Schwannoma
Beijing Tiantan Hospital
Phase 1/2
30
Beijing, Changchun, Shanghai
2026-07-31
Recruiting
IPG1094 Phase I Study for China Healthy Participants
NCT07679113Healthy Volunteers
Nanjing Immunophage Biotech Co., Ltd
Phase 1
24
Shanghai
2026-07-30
Recruiting
Sacituzumab Govitecan Combined With Tislelizumab for Locally Advanced/Metastatic Esophageal Cancer
NCT07811752Esophageal Squamous Cell Carcinoma
Shanghai Chest Hospital
Phase 2
28
Shanghai
2026-07-30
Recruiting
T2AIR: Real-World Efficacy and Safety of Biologics Targeting Type 2 Inflammation in Asthma and COPD
NCT07823842Asthma, COPD (Chronic Obstructive Pulmonary Disease)
Shanghai Pulmonary Hospital, Shanghai, China
Observational
538
Shanghai
2026-07-30
Not yet open
Evaluation of the Safety, Tolerability and Pharmacokinetics of TUL108 for Injection in Healthy Participants (SAD/ MAD)
NCT07719257Complicated Urinary Tract Infections(cUTI)
Zhuhai United Laboratories Co., Ltd.
Phase 1
72
Shanghai
2026-07-30
Recruiting
A Clinical Study of HRS-7525 Tablets in Patients With Advanced Prostate Cancer
NCT07711184Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 1
320
Shanghai
2026-07-30
Recruiting
A Study of Teprotumumab N01 in Subjects With Active Thyroid Eye Disease
NCT07265258Thyroid Eye Disease
Innovent Biologics (Suzhou) Co. Ltd.
Phase 4
92
Shanghai
2026-07-30
Recruiting
Hippocampal Temporal Interference Stimulation for Memory and Dual-Task Postural Control in Older Adults With Mild Cognitive Impairment
NCT07771036Mild Cognitive Impairment (MCI)
Shanghai University of Sport
Not applicable
21
Shanghai
2026-07-30
Recruiting
A Phase I Clinical Study of HLX3902 in Patients With mCRPC and Other Advanced Tumours
NCT07533708mCRPC or Advanced/Metastatic Solid Tumors
Shanghai Henlius Biotech
Phase 1
48
Nanchang, Naning, Nanjing, Shanghai, Xiamen
2026-07-30
Recruiting
First-in-Human Trial of VBC108 in Participants With Advanced Malignant Solid Tumors
NCT07700160Advanced Solid Tumors
VelaVigo Bio Inc
Phase 1/2
230
Beijing, Shanghai, Hangzhou
2026-07-30
Recruiting
A Phase 2 Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib (LOU064) in Adult Patients With Papulopustular Rosacea (PPR)
NCT07681271Papulopustular Rosacea
Novartis Pharmaceuticals
Phase 2
100
Shanghai
2026-07-30
By invitation
Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer
NCT07441369Liver Metastases From Colorectal Cancer (mCRC)
Fudan University
Phase 2
16
Shanghai
2026-07-30
Recruiting
A Study to Evaluate GFH375 Versus Docetaxel in Participants With Non-Small Cell Lung Cancer With KRAS G12D Mutation
NCT07668752KRAS G12D Mutation, NSCLC (Non-small Cell Lung Cancer)
Genfleet Therapeutics (Shanghai) Inc.
Phase 3
300
Shanghai
2026-07-27
Recruiting
A Phase II Study to Evaluate the Efficacy and Safety of SKB571 in Recurrent or Metastatic HNSCC Participants
NCT07668154HNSCC
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2
120
Chengdu, Shanghai
2026-07-27
Recruiting
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
NCT07492680Solid Tumors
Bristol-Myers Squibb
Phase 2
260
Beijing, Chongqing, Guangzhou, Xinxiang, Shanghai
2026-07-27
Rows per page Showing 101–200 of 3827
Previous 1 2 3 4 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china/city/shanghai?page=2

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.